Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Clin Exp Obstet Gynecol ; 43(2): 220-4, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27132414

RESUMEN

OBJECTIVE OF THE STUDY: To study the production of pro-inflammatory (IL-1ß, IL- 2, IL-6, IL-8) and anti-inflammatory (IL-4, IL-10) cytokines in pregnancy complicated by preeclampsia in the third trimester. Institution: University Clinic of Gynecology and Obstetrics, Skopje, Republic of Macedonia. MATERIAL AND METHODS: Fifty women with pregnancies complicated by preeclampsia in the third trimester and 50 women with physiological pregnancy. Levels of IL-1ß, IL-2, IL-6, IL-8, IL-4, and IL-10 were measured by using a solid-phase enzyme immunoassay. Statistical data processing was done using the application program SPSS for Windows 13.0. To describe the distribution of analyzed variables, descriptive methods (mean, median, minim and max) were used . RESULTS: In pregnancies complicated by preeclampsia, there are increased levels of proinflammatory cytokines and a change in the behaviour of opposing pools. Most pronounced changes in the levels of proinflammatory cytokines were observed in mild preeclampsia. In severe preeclampsia there was reduction of the concentration of anti-inflammatory cytokines IL-4 and IL-10. CONCLUSION: The use of assessment cytokine profile monitoring of health status of women with preeclampsia is expedient.


Asunto(s)
Citocinas/inmunología , Preeclampsia/inmunología , Adulto , Estudios de Casos y Controles , Femenino , Humanos , Interleucina-10/inmunología , Interleucina-1beta/inmunología , Interleucina-2/inmunología , Interleucina-4/inmunología , Interleucina-6/inmunología , Interleucina-8/inmunología , Embarazo , Tercer Trimestre del Embarazo , Índice de Severidad de la Enfermedad
2.
Acta Neurol Scand ; 132(3): 196-202, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25691245

RESUMEN

OBJECTIVES: Fever frequently occurs in stroke patients and worsens their prognosis. However, only few studies have assessed the determinants of fever in acute stroke, and no study has specifically addressed the possible prediction of the development of fever. MATERIALS AND METHODS: This investigation included 536 patients with acute stroke and a body temperature <=37°C during the first 24 h of stay. Ninety-two of them (17.2%) subsequently developed fever (defined as a temperature >=37.5°C starting after 24 h). Among the clinical variables available during the first 24 h from admission, those predictive of the subsequent appearance of fever were searched for. One hundred further patients had a temperature >37°C during the first 24 h. RESULTS: In univariate analysis, many variables were predictive of the subsequent development of fever, but in multivariate analysis, only the following four predictors remained significant (odds ratio [95% confidence interval], P value): nasogastric tube (4.0 [2.2-7.4], <0.0001), atrial fibrillation (2.3 [1.4-3.8], 0.001), total anterior circulation syndrome (2.0 [1.2-3.5], 0.01), and urinary catheter (1.9 [1.1-3.3], 0.01). Among the 52 (9.7%) patients with three or four predictors, 31 (59.6%) subsequently developed fever. In addition, the factors independently associated with a temperature >37°C during the first 24 h were as follows: National Institutes of Health Stroke Scale (P < 0.0001), hemorrhagic stroke (P = 0.0008), atrial fibrillation (P = 0.002), and total parenteral nutrition (P = 0.03). CONCLUSIONS: In patients with acute stroke, four clinical variables were found to be independently associated with the risk of developing fever and, of them, nasogastric tube was the strongest and most significant one.


Asunto(s)
Fiebre/etiología , Intubación Gastrointestinal/efectos adversos , Accidente Cerebrovascular/complicaciones , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Oportunidad Relativa , Pronóstico , Factores de Riesgo , Estados Unidos
3.
Environ Monit Assess ; 186(12): 8291-301, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25154683

RESUMEN

Being able to identify the environmental crimes and the guilty parties is central to police investigations, and new technologies enable the authorities to do this faster and more accurately than ever before. In recent years, our research team has introduced the use of a range of aerial platforms and an innovative application of thermography to detect several illegal activities; for example, illegal sanitary sewer and storm-drain connections, illicit wastewater discharges, and other "anomalies" on surface waters can be easily identified using their thermal infrared signatures. It can also be used to detect illegal solid/liquid waste dumps or illicit air discharges. This paper introduces first results of a Thermal Pattern and Thermal Tracking approach that can be used to identify different phenomena and several pollutants. The aims of this paper were to introduce a fingerprint paradigm for environmental police investigations, defining several specific signatures (patterns) that permit the identification of an illicit/anomalous activity, and establish a procedure to use this information to find the correlation (tracking) between the crime and the culprit or the source and the target.


Asunto(s)
Crimen , Monitoreo del Ambiente/métodos , Sustancias Peligrosas/análisis , Policia , Tecnología de Sensores Remotos , Termografía
4.
Med Lav ; 104(3): 224-35, 2013.
Artículo en Italiano | MEDLINE | ID: mdl-23879066

RESUMEN

BACKGROUND: Cutaneous carcinomas are tumors with a potential occupational etiology due to exposure to established carcinogens such as polycyclic aromatic hydrocarbons (PAH), ionizing radiation, ultraviolet (UV) radiation and arsenic. The occupational origin of such neoplasms is hugely underestimated in Italy. OBJECTIVES: To asses the proportion of Squamous Cell Carcinomas (SCC) cases with a previous occupational exposure to carcinogens. METHODS: We systematically evaluated occupational exposure in a series of consecutive cases, discharged in the period 2010-11 from the Dermatology Unit of Varese Hospital, Italy, with a histological diagnosis of SCC. Through a structured telephone interview we identified patients with a potential exposure to skin carcinogens. As a second-level step, an extensive evaluation by an occupational physician was performed to assess the occupational etiology in those selected cases. RESULTS: 105 patients were identified (65 men). 15 male cases out of a total of 85 patients who did the telephone interview, revealed a potential occupational exposure; 7 cases were confirmed as occupational cancers after second-level evaluation (proportion of male occupational cases = 13.2%). UV radiation and PAH were recognized as major causal agents. Applying those results to the national incidence data, we estimated a number of 700 annual occupational cases, 100-fold more than the cases currently evaluated by the Italian National Workers Compensation Authority. CONCLUSIONS: Our results revealed that occupational SCC is still at present a substantially "lost disease" in Italy. Greater attention and enhanced collaboration between specialists is thus needed to overcome this tendency.


Asunto(s)
Carcinoma de Células Escamosas/epidemiología , Enfermedades Profesionales/epidemiología , Exposición Profesional/estadística & datos numéricos , Neoplasias Cutáneas/epidemiología , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Italia/epidemiología , Masculino , Persona de Mediana Edad , Encuestas y Cuestionarios
6.
Transplantation ; 51(2): 433-8, 1991 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-1847251

RESUMEN

Twenty-seven patients received pulmonary transplants during the period since we began routine use of cytomegalovirus-seronegative blood products for CMV-seronegative recipients. Preoperative serologic status of the recipient and the occurrence of cytomegalovirus infection in the postoperative period were correlated with development of obliterative bronchiolitis (OB) as diagnosed by transbronchial biopsy (TBB). Patients included 20 heart-lung and 7 double-lung recipients. OB occurred in 18 of 27 patients. All 3 CMV seronegative recipients receiving lungs from a seropositive donor and 9 of 10 CMV recipients seropositive at the time of transplantation developed OB compared with only 6 of 14 CMV seronegative patients receiving seronegative grafts (P = 0.018). CMV infection occurred in 10/27 patients, of whom 5 were asymptomatic; 90% of these patients developed OB. Donor-specific alloreactivity, based on primed lymphocyte testing (PLT) of bronchoalveolar lavage cells was found at the time of diagnosis of OB in 23 of 27 patients. A positive PLT was significantly associated with the presence of OB (P = 0.017). We conclude that preoperative seropositive status for CMV, grafting of organs from seropositive donors, and postoperative CMV infection are significant risk factors for developing OB. That OB is, in part, an immunologically mediated form of injury and represents chronic rejection is supported by the presence of donor-specific alloreactivity in BAL lymphocytes from all recipients with OB.


Asunto(s)
Bronquiolitis Obliterante/complicaciones , Infecciones por Citomegalovirus/complicaciones , Citomegalovirus/inmunología , Trasplante de Pulmón/inmunología , Anticuerpos Antivirales/análisis , Rechazo de Injerto , Humanos , Factores de Riesgo
7.
Methods Mol Med ; 2: 173-83, 1996.
Artículo en Inglés | MEDLINE | ID: mdl-21359742

RESUMEN

Cystic fibrosis (CF) is the most frequent (incidence around l/2500 live births) genetic cause of death among Caucasians. It is an autosomal recessive disorder compromising the secretory epithelia. Clinically, CF is a polymorphic disease showing abnormal functioning of the airways, the digestive apparatus (pancreas and intestine), the reproductive tract, and the sweat glands, leading to respiratory insufficiency, mainutrition, male sterility, and production of salty sweat. The average life-span of CF patients falls around 25-30 yr of age in the United States and Europe, and around 10 yr of age in Latin America (1, 2). Respiratory infections are the cause of death of more than 90% of CF patients. No curative treatments are as yet available for CF.

8.
J Chemother ; 3(1): 30-8, 1991 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-2019860

RESUMEN

Twenty-three patients suffering from lower respiratory tract infections caused by Gram-negative germs were treated with aztreonam (AZT) administered according to two different regimens: 17 subjects (Group A) with 2 g i.v. every 12 h and 6 patients (Group B) with 4 g in 100 ml of saline every 24 hours. Group A included 8 cases of superinfected bronchiectasis, 8 purulent bronchitis and 1 gangrene caused by Gram-negative and anaerobic agents. Group B comprised 6 patients with severe bronchiectasis infection. Pseudomonas aeruginosa was isolated from the sputum in 10/23 cases. The treatment was performed for 10 days on the average. The local and systemic tolerability was good. Group B, with higher antibiotic sputum concentrations for at least 12 hours, attained a better response than Group A: with clinical cure in 100% vs 76% cured plus 18% improved patients; therapy lasted 9.5 days for Group B vs 10.8 days for Group A. Moreover, in 14 subjects affected by pulmonary interstitial diseases who underwent diagnostic broncho-alveolar lavage, we dosed AZT in lavage fluids about 1 hour after the injection of a 2 g dose (Group C: 8 cases) or a 4 g dose (Group D: 6 cases). In group D antibiotic concentrations were significantly higher (P less than 0.005) than group C, while all the parameters that usually define the intensity of the alveolar alterations were not significantly different. Therefore, aztreonam administration in a daily monodose seems able to assure higher and longer lasting concentrations at the site of infection.


Asunto(s)
Aztreonam/administración & dosificación , Aztreonam/farmacocinética , Enfermedades Pulmonares/tratamiento farmacológico , Adulto , Anciano , Anciano de 80 o más Años , Aztreonam/sangre , Disponibilidad Biológica , Líquido del Lavado Bronquioalveolar/metabolismo , Esquema de Medicación , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Esputo/metabolismo
9.
Tumori ; 74(1): 7-10, 1988 Feb 29.
Artículo en Inglés | MEDLINE | ID: mdl-2451333

RESUMEN

Angiogenic capacity was tested in 14 non-Hodgkin's lymphomas, 7 Hodgkin's lymphomas and 15 cervical lymph nodes nonneoplastic but draining a territory with a laryngeal carcinoma. The objective was to find out whether different groups of lymphomas showed differences in their angiogenic capacity and to compare the ability to induce neovascularization of neoplastic lymphocytes. Frequency and intensity of the angiogenic response were similar for classes of lymphomas different for morphologic and immunologic characteristics. The presence of a carcinoma was sufficient to induce in tributary, nonmetastatic lymph nodes an angiogenic activity comparable to that known to characterize antigenically stimulated lymphocytes.


Asunto(s)
Enfermedad de Hodgkin/patología , Ganglios Linfáticos/patología , Linfoma no Hodgkin/patología , Neovascularización Patológica , Animales , Carcinoma/patología , Córnea , Humanos , Hiperplasia , Neoplasias Laríngeas/patología , Ganglios Linfáticos/trasplante , Conejos
10.
Prilozi ; 32(1): 155-71, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21822185

RESUMEN

BACKGROUND: The goal of this study was to examine the impact of body mass index (BMI) and age on the outcome of the IVF process. MATERIALS AND METHODS: This was a retrospective case-control study, of all patients undergoing IVF from 2008-2010 in the Re-Medika IVF Centre. A total of 1238 fresh, non-donor IVF cycles were analyzed, but to minimize the bias, only the first cycle for each patient in that period was analysed (N-920). The patients underwent standard protocols for COH and embryology treatment. In all retrieved oocytes, or in 100% of the cases, the process of fertilization was realized with the method of intracytoplasmic sperm insemination (ICSI). The primary end-point assessed was clinical pregnancy rate. Patients were initially grouped into four BMI categories. The data are presented as frequencies (qualitative data) and as mean±SD (quantitative data). Preliminary comparisons between groups with different BMI were made by the Chi-square and one-way ANOVA test. Because fertility declines with age, there is a Pearson-correlation coefficient to see if BMI depends on age, and the resulting value r=0.15 (p<0.05) showed that BMI is age-dependent, the relationship between them showed multicollinearity. However, the calculated error tolerance of 0.9 indicates stability of the model. Furthermore, to adjust the known fertility decline with age, every response or outcome is analysed by the method of multiple linear (continuous data) or logistic (qualitative data) regression, where the independent variables are taken: BMI, age and BMI interaction×age. RESULTS: Increased BMI significantly reduces the chance of clinical pregnancy (normal weight vs. overweight: clinical pregnancy rate: 49.2%, vs. 34.3%). Age, analysed as a single factor, significantly reduces clinical pregnancy rate. Interaction of BMI and age significantly affects clinical pregnancy rate. (BMI vs. BMI×Age vs. Age-p 0,01 vs. 0,001 vs. <0,0001). CONCLUSION: Increased body mass of patients entering IVF has a negative impact on the final outcome and certainly reduces the success of the process resulting in reduced clinical pregnancy. Interaction of BMI and age showed a strong significant impact on the outcome of IVF seen through the achievement of clinical pregnancy.


Asunto(s)
Fertilización In Vitro , Infertilidad Femenina , Sobrepeso , Adulto , Factores de Edad , Índice de Masa Corporal , Estudios de Casos y Controles , Femenino , Fertilización In Vitro/métodos , Fertilización In Vitro/estadística & datos numéricos , Humanos , Infertilidad Femenina/complicaciones , Infertilidad Femenina/epidemiología , Infertilidad Femenina/terapia , Evaluación de Resultado en la Atención de Salud , Sobrepeso/complicaciones , Sobrepeso/diagnóstico , Sobrepeso/epidemiología , Embarazo , Índice de Embarazo , República de Macedonia del Norte/epidemiología , Estudios Retrospectivos , Medición de Riesgo/métodos , Factores de Riesgo , Insuficiencia del Tratamiento
11.
Prilozi ; 31(2): 51-9, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-21258277

RESUMEN

OBJECTIVE: The aim of the present study was to determine the prevalence of abnormal thyroid function and antithyroid antibodies during pregnancy in women with diabetes type 1 and gestational diabetes mellitus (GDM). METHODS: The study group included 83 pregnant women who attended the Outpatient Department of the Endocrinology, Diabetes and Metabolic Disorders Clinic in the period from 05.2009 to 11.2009. The one hundred-g. oral glucose tolerance test (OGTT) was conducted on the pregnant women except for women with diabetes type 1. Thyroid functions were evaluated in all the pregnant women. After routine screening for GDM, thirty of the pregnant women were healthy and GDM was diagnosed in forty of them. The rest, thirteen women, had diabetes type 1. RESULTS: The women who developed GDM showed a mean free thyroxin concentration (fT4) significantly lower than that observed in the healthy pregnant women and women with diabetes type 1. Among the pregnant women with GDM, 10 women or 25% had fT4 concentrations below the lower cut-off with normal thyroid-stimulating hormone concentrations (TSH). A statistically significant difference was found in the prevalence of antithyroid antibodies (anti-TPO) between the (30%) women with diabetes type 1 and (10%) healthy pregnant women (p<0.05). In the women positive for anti-TPO, TSH was significantly higher (p<0.05). CONCLUSION: The significantly higher prevalence of hypothyroxinemia in GDM pregnancies and anti-TPO titres in pregnancies with diabetes type 1, than in healthy pregnant women warrants routine screening for thyroid abnormalities in these groups of pregnant women.


Asunto(s)
Diabetes Gestacional/inmunología , Diabetes Gestacional/fisiopatología , Enfermedades de la Tiroides/epidemiología , Glándula Tiroides/fisiopatología , Adulto , Diabetes Mellitus Tipo 1 , Diabetes Gestacional/sangre , Femenino , Humanos , Embarazo , Embarazo en Diabéticas , Prevalencia , Tiroiditis Autoinmune/epidemiología , Tirotropina/sangre , Tiroxina/sangre
14.
G Batteriol Virol Immunol ; 80(1-12): 207-14, 1987.
Artículo en Italiano | MEDLINE | ID: mdl-3509028

RESUMEN

Several cases of human dirofilariasis has been recently reported in literature; the localization of parasite was especially in subcutaneous tissues. A case of ocular dirofilariasis observed in a woman living in a country near Turin is described. The worm was an immature female with characters in agreement with the description of Dirofilaria conjunctivae (Addario, 1885), nematode responsible of an high percentage of canine filariasis.


Asunto(s)
Enfermedades de la Conjuntiva/etiología , Dirofilariasis/complicaciones , Anciano , Animales , Enfermedades de la Conjuntiva/parasitología , Dirofilaria/anatomía & histología , Femenino , Humanos
15.
J Allergy Clin Immunol ; 81(2): 429-37, 1988 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-2828452

RESUMEN

Although peripheral blood eosinophilia is a prominent feature of asthma, the contribution of eosinophils to asthma has yet to be fully comprehended. Furthermore, study of isolated eosinophil function in asthma has been complicated by difficult purification methods and, now, the presence of hypodense eosinophils. In our study, eosinophils were isolated from normal subjects and patients with asthma. Two principal evaluations were performed: (1) a comparison of the density-gradient profiles on peripheral blood leukocytes from normal subjects and patients with asthma and (2) a comparison of the chemiluminescence (CL) response with normal dense eosinophils from these two study groups. Granulocyte preparations were initially isolated from Ficoll-Hypaque gradients and were then applied to a continuous Percoll density gradient. In asthma, 40.8 +/- 5.8% of the peripheral blood eosinophils were hypodense (defined as a density less than 1.081 gm/ml), whereas normal subjects had only 9.1 +/- 1.9% of this subpopulation (p less than 0.01). Functional assessment of purified (greater than 90%) normal dense eosinophils was made by measurement of CL to opsonized zymosan particles and the soluble stimulus phorbol myristate acetate. In asthma, eosinophil CL to zymosan, but not phorbol myristate acetate, was significantly less. Differences in eosinophil CL between normal subjects and subjects with asthma did not correlate with the severity of airway obstruction or the peripheral blood eosinophil count. The reasons for the appearance of hypodense eosinophils and diminished metabolic activity in asthma are not established but raise the possibility that their presence represents previous eosinophil activation.


Asunto(s)
Asma/sangre , Centrifugación por Gradiente de Densidad , Eosinofilia/sangre , Eosinófilos/clasificación , Mediciones Luminiscentes , Adulto , Separación Celular , Eosinófilos/efectos de los fármacos , Eosinófilos/ultraestructura , Femenino , Humanos , Recuento de Leucocitos , Masculino , Neutrófilos/metabolismo , Povidona , Dióxido de Silicio , Zimosan/farmacología
16.
Am Rev Respir Dis ; 145(5): 1036-41, 1992 May.
Artículo en Inglés | MEDLINE | ID: mdl-1586043

RESUMEN

Tumor necrosis factor-alpha (TNF alpha) is a cytokine produced by mononuclear cells that amplifies inflammation and modulates expression of Class I and Class II histocompatibility antigens. Because of these properties, this cytokine may exert a central role in both the defense and the rejection of the transplanted lung. Utilizing an ELISA technique, we measured TNF alpha in vivo and in vitro in several compartments of lung transplant recipients and in normal subjects that included serum, bronchoalveolar lavage fluid (BAL), and media conditioned by alveolar macrophages (AM) and by autologous peripheral blood monocytes (PBM). Overall, stimulated production of TNF alpha by AM from lung recipients in vitro was less than that of cells from normal subjects in response to lipopolysaccharide (LPS) challenge, and stimulated production of TNF alpha by AM harvested during conditions of infection or acute and chronic rejection was less than that by cells from healthy lung recipients. AM from normal subjects and allograft recipients produced substantially more TNF alpha than autologous PBM, but release in vitro by PBM from recipients was the same as that from cells of normal subjects who were not immunosuppressed. Thus, systemic immunosuppression does not seem to affect the production of TNF alpha by PBM in vitro, but it may reduce production by AM, indicating different effects of immunosuppression on different compartments of mononuclear cells. This mediator was not detected at elevated levels in serum, and it was undetectable in BAL fluid. We conclude that AM from lung recipients are capable of producing TNF alpha, which would influence the defense and immunogenicity of the allograft.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Rechazo de Injerto/inmunología , Trasplante de Corazón-Pulmón/inmunología , Macrófagos Alveolares/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Adulto , Líquido del Lavado Bronquioalveolar/química , Líquido del Lavado Bronquioalveolar/citología , Células Cultivadas , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Terapia de Inmunosupresión , Masculino , Infecciones del Sistema Respiratorio/inmunología
17.
Respiration ; 59 Suppl 1: 50-2, 1992.
Artículo en Inglés | MEDLINE | ID: mdl-1579737

RESUMEN

The bronchoalveolar compartment can be easily investigated with BAL (bronchoalveolar lavage) before and after antiblastic therapy. We studied 50 patients affected by primary lung cancer, of whom 31 served as a control group and 19 were submitted to BAL after chemo- and/or radiotherapy. Data from BAL performed in an unaffected lung area show that antiblastic therapy can produce alterations in the terminal airways without clinical evidence. Chemotherapy causes a significant impairment of the alveolo-capillary barrier. Radiotherapy is able to affect lymphocytes, with a CD4/CD8 reduction. The concomitance of both therapies produces synergistic effects. Immunomodulant therapy with thymostimulin in otherwise untreated lung cancer patients seems able to modify alveolar lymphocyte number and subsets, but these are preliminary data which need further substantiation.


Asunto(s)
Líquido del Lavado Bronquioalveolar/citología , Neoplasias Pulmonares/terapia , Extractos del Timo/uso terapéutico , Relación CD4-CD8 , Terapia Combinada , Humanos , Recuento de Leucocitos , Neoplasias Pulmonares/tratamiento farmacológico , Neoplasias Pulmonares/patología , Neoplasias Pulmonares/radioterapia , Linfocitos/inmunología
18.
J Eur Acad Dermatol Venereol ; 13(2): 91-5, 1999 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-10568486

RESUMEN

BACKGROUND: The aim of this clinical trial was to assess the efficacy and safety of calcipotriol cream associated with oral etretinate compared with etretinate alone in the treatment of moderate-severe psoriasis. METHODS: This controlled multicenter trial, within patients (hemiparts), enrolled 86 in- or out-patients (62 males, 24 females), mean (+/-SD) age 57.1 +/- 14.2 years, with psoriasis vulgaris on both sides of the body, and mean (+/-SE) baseline PASI score (Psoriasis Area and Severity Index) 30.7 +/- 0.9. All patients took oral etretinate 50 mg/day and applied calcipotriol cream (50 microg/g) on one half of their body twice a day. Treatment was continued for 9 weeks, and patients were seen every 3 weeks. RESULTS: At the end of the first 3 weeks the PASI score indicated a significant clinical difference between the two sides of the body (P < 0.001, ANOVA), with a reduction of 50.7% in the score for the calcipotriol-treated half, compared with a 39% reduction for the untreated half. By the 9th week of treatment the PASI score was 81.4% lower on the treated half, and 70.3% on the untreated side (P < 0.001, ANOVA). CONCLUSIONS: These findings suggest that patients with moderate-severe psoriasis might benefit from treatment with etretinate plus calcipotriol, with the aim of achieving a faster response and an overall smaller total dose of etretinate.


Asunto(s)
Calcitriol/análogos & derivados , Fármacos Dermatológicos/uso terapéutico , Etretinato/uso terapéutico , Queratolíticos/uso terapéutico , Psoriasis/tratamiento farmacológico , Administración Oral , Administración Tópica , Adulto , Anciano , Anciano de 80 o más Años , Calcitriol/administración & dosificación , Calcitriol/uso terapéutico , Fármacos Dermatológicos/administración & dosificación , Quimioterapia Combinada , Etretinato/administración & dosificación , Femenino , Humanos , Queratolíticos/administración & dosificación , Masculino , Persona de Mediana Edad , Psoriasis/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA